San Diego, United States
Serenium is a digital health company with a mission to make medical diagnosis easy, affordable, and available to everyone in the world. Founded in 2014 and headquartered in the United States, the company aims to revolutionize the healthcare industry. With the slogan "Making medical diagnosis easy, affordable, and available to everyone in the world," Serenium focuses on leveraging IoT, cloud computing, and machine learning technologies for its innovative solutions.
One of Serenium's flagship offerings, pending CFDA and FDA approval, is a sleep apnea diagnosis system. This solution utilizes IoT, cloud computing, and machine learning to provide a significantly cheaper and scalable alternative to current home sleep tests and clinic sleep labs. By incorporating cutting-edge technologies, Serenium addresses the accessibility and cost issues surrounding medical diagnosis, thereby enhancing the overall healthcare experience for individuals worldwide.
Currently, there is no information available regarding Serenium's latest investment details, including the investment amount and the participating investors. However, given the company's strong focus on driving positive change in the healthcare sector and its innovative approach to medical diagnosis, Serenium presents an intriguing opportunity for potential investors seeking to support disruptive advancements in the health tech industry.
